| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.66B | $1.54B | $1.48B |
| YoY Revenue Growth % | +7.5% | +3.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.36B | $3.05B | $3.23B |
| Operating Margin % | 203.0% | 198.2% | 218.0% |
| Net Income (GAAP) | $2.85B | $2.59B | $2.74B |
| EBITDA (Normalized) | $3.42B | $3.11B | $3.29B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.00B | $3.61B | $3.90B |
| Capital Expenditures (CapEx) | $74.6M | $69.3M | $66.8M |
| Free Cash Flow (FCF) | $2.93B | $3.54B | $3.84B |
| FCF Margin % | 176.7% | 229.8% | 258.6% |
| Return on Invested Capital (ROIC %) | 3.0% | 2.8% | 23.8% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $82.95B | $80.59B | $4.16B |
| Total Stockholders' Equity | $29.18B | $29.03B | $8.54B |